Is Personalis Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Personalis Inc (PSNL) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Personalis Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Personalis Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Personalis Inc?

Muslim investors may consider investing in Personalis Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Personalis Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Personalis Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Personalis Inc updated?

The Shariah compliance status of Personalis Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Personalis Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Personalis Inc?

You can check the latest Shariah compliance status of Personalis Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

PSNL Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 02, 2026

Report Source: 2025 Annual Report

Personalis Inc. Stock Analysis PSNL

United States Health Care Small Cap Report: 2025 Annual

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The company is headquartered in Fremont, California and currently employs 260 full-time employees. The company went IPO on 2019-06-20. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The firm performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.

Key Statistics of Personalis Inc (PSNL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$6.32$6.59

Today's Open

$6.52

Volume

1.77M

P/E Ratio (TTM)

52 Week Range

$3.84$11.50

Market Cap

582.01M

Avg. Volume

2.31M

Dividend Yield

Financial Metrics & Statements of Personalis Inc (PSNL)

FAQ's for Personalis Inc (PSNL)

According to Musaffa’s Shariah screening methodology, Personalis Inc (PSNL) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.